CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
JW Shinyak Corp Company Snapshot
JW Shinyak Corp operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares JW Shinyak Corp with three other companies in this sector in South Korea: Binex Company Ltd (2017 sales of 78.03 billion Korean Won [US$73.27 million] of which 83% was Pharmaceutical), Dongsung Pharmaceutical Company Limited (82.39 billion Korean Won [US$77.36 million] of which 92% was Pharmaceutical Segment), and Wooridul Pharmaceutical Limited (79.89 billion Korean Won [US$75.02 million] of which 100% was Pharmaceutical).

Sales Analysis. JW Shinyak Corp reported sales of 76.84 billion Korean Won (US$72.16 million) for the year ending December of 2017. This represents a decrease of 7.8% versus 2016, when the company's sales were 83.38 billion Korean Won. The sales level in 2017 was fairly close to the level five years ago: in 2012, JW Shinyak Corp had sales of 69.92 billion Korean Won.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
JW Shinyak Corp
  Stock Performance Chart for JW Shinyak Corp
 
  Stock Data: Recent Stock Performance:
  Current Price (4/20/2018): 10,750
(Figures in Korean Won)
1 Week -11.5%   13 Weeks 27.1%  
4 Weeks 18.7%   52 Weeks 30.3%  
 
JW Shinyak Corp Key Data:
  Ticker: 067290 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 76,842,747,509
(Year Ending Jan 2018).
Employees: 226
  Currency: Korean Won Market Cap: 434,604,773,250
  Fiscal Yr Ends: December Shares Outstanding: 40,428,351
  Share Type: Common Closely Held Shares: 13,492,327
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.